Patents by Inventor Gene Gauzer

Gene Gauzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10722493
    Abstract: Methods of treating fibroproliferative disorders mediated by ?-catenin in mammals, including aggressive fibromatoses, also called desmoid tumour.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: July 28, 2020
    Assignee: The Hospital for Special Children
    Inventors: Benjamin A. Alman, Raymond Poon, Helen Hong, Gene Gauzer
  • Publication number: 20170281594
    Abstract: A topical drug composition for treating a ?-catenin-mediated disorder in a mammal is provided comprising a Nefopam compound selected from Nefopam, or a functionally equivalent analogue, prodrug, salt or solvate thereof.
    Type: Application
    Filed: May 19, 2017
    Publication date: October 5, 2017
    Inventors: Benjamin A. Alman, Raymond Poon, Helen Hong, Gene Gauzer
  • Publication number: 20170172980
    Abstract: A topical drug composition for treating a ?-catenin-mediated disorder in a mammal is provided comprising a Nefopam compound selected from Nefopam, or a functionally equivalent analogue, prodrug, salt or solvate thereof.
    Type: Application
    Filed: December 24, 2016
    Publication date: June 22, 2017
    Inventors: Benjamin A. Alman, Raymond Poon, Helen Hong, Gene Gauzer
  • Patent number: 9566263
    Abstract: A topical drug composition for treating a ?-catenin-mediated disorder in a mammal is provided comprising a Nefopam compound selected from Nefopam, or a functionally equivalent analog, prodrug, salt or solvate thereof.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: February 14, 2017
    Assignee: Hospital for Sick Children
    Inventors: Benjamin A. Alman, Raymond Poon, Helen Hong, Gene A. Gauzer
  • Publication number: 20070218139
    Abstract: Methods for producing a pharmaceutical preparation of pressure-fused particles including an active pharmaceutical ingredient are disclosed. The methods include the application of a pressure of between 0.1 GPa and 10 GPa to produce a compacted sample. The pressure-fused particles of the invention are useful for parenteral administration, and particularly sustained-release formulations, due to dissolution kinetics which are superior to conventional crystalline or amorphous packed powder preparations of active pharmaceutical ingredients. Pharmaceutical preparations including such pressure-fused microparticles are also disclosed.
    Type: Application
    Filed: December 22, 2003
    Publication date: September 20, 2007
    Inventors: Thomas Smith, Gene Gauzer